Average Co-Inventor Count = 6.92
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (24 from 666 patents)
2. Incyte Holdings Corporation (9 from 147 patents)
24 patents:
1. 12421197 - Aminopyrazine derivatives as PI3K-γ inhibitors
2. 12173006 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
3. 12152033 - Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders
4. 12030885 - Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors
5. 11926630 - Tertiary alcohols as PI3K-γ inhibitors
6. 11819505 - Heterocyclylamines as PI3K inhibitors
7. 11780840 - Tricyclic urea compounds as JAK2 V617F inhibitors
8. 11661422 - Tricyclic urea compounds as JAK2 V617F inhibitors
9. 11433071 - Heterocyclylamines as PI3K inhibitors
10. 11225486 - Tertiary alcohols as PI3K-γ inhibitors
11. 11186580 - Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
12. 11046658 - Aminopyrazine derivatives as PI3K-γ inhibitors
13. 10975088 - Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
14. 10738057 - Tertiary alcohols as PI3K-γ inhibitors
15. 10479795 - Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors